INCOME STATEMENT
Mankind Pharma Ltd.
BSE
Jul 04
2439.30
+75.80 (+ 3.21%)
Volume
69448
Prev. Close
2363.50
Open Price
2374.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jul 04
2439.50
+77.80 (+ 3.29%)
Volume
1061825
Prev. Close
2361.70
Open Price
2361.70
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE634S01028
|
Market Cap. ( ₹ in Cr. )
|
100685.18
|
P/BV
|
9.53
|
Book Value ( ₹ )
|
256.00
|
BSE Code
|
543904
|
52 Week High/Low ( ₹ )
|
3055/1901
|
FV/ML
|
1/1
|
P/E(X)
|
50.57
|
NSE Code
|
MANKINDEQ
|
Book Closure
|
|
EPS ( ₹ )
|
48.24
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 9497.80 | 9263.66 | 8120.57 | 7240.86 | 5486.16 |
Other Operating Revenues | 0.00 | 1.15 | 6.58 | 16.17 | 43.44 |
Total Operating Revenues | 9497.80 | 9264.81 | 8127.15 | 7257.04 | 5529.60 |
| | | | | |
Other Income | 493.21 | 266.64 | 162.78 | 162.73 | 148.08 |
Total Revenue | 9991.01 | 9531.45 | 8289.94 | 7419.77 | 5677.68 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 800.43 | 861.74 | 711.05 | 772.24 | 494.53 |
Purchase Of Stock-In Trade | 1809.96 | 2071.92 | 1865.82 | 2014.37 | 1541.89 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -13.50 | -25.36 | 267.89 | -352.01 | -254.25 |
Employee Benefit Expenses | 2131.67 | 1982.10 | 1701.38 | 1443.83 | 1106.14 |
Finance Costs | 371.76 | 14.57 | 27.75 | 43.83 | 7.98 |
Provisions And Contingencies | 15.82 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation And Amortisation Expenses | 378.01 | 317.61 | 269.58 | 120.98 | 78.19 |
Other Expenses | 2190.87 | 2049.30 | 1883.64 | 1578.99 | 1263.00 |
Total Expenses | 7685.02 | 7271.88 | 6727.10 | 5622.23 | 4237.47 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2305.99 | 2259.57 | 1562.84 | 1797.54 | 1440.21 |
| | | | | |
Profit/Loss Before Tax | 2305.99 | 2259.57 | 1562.84 | 1797.54 | 1440.21 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 421.74 | 416.56 | 296.00 | 399.58 | 344.89 |
Deferred Tax | 0.00 | 19.60 | 30.30 | 49.09 | 8.84 |
Tax For Earlier Years | 0.00 | 0.00 | -11.72 | 13.74 | 2.10 |
Total Tax Expenses | 421.74 | 436.16 | 314.58 | 462.41 | 355.83 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 1884.25 | 1823.41 | 1248.26 | 1335.13 | 1084.37 |
| | | | | |
Extraordinary Items | 61.23 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit/Loss From Continuing Operations | 1945.48 | 1823.41 | 1248.26 | 1335.13 | 1084.37 |
| | | | | |
Profit/Loss For The Period | 1945.48 | 1823.41 | 1248.26 | 1335.13 | 1084.37 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 48.16 | 45.52 | 31.16 | 33.33 | 27.07 |
Diluted EPS (Rs.) | 48.07 | 45.45 | 31.16 | 33.33 | 27.07 |